Premium
Sonnet BioTherapeutics Holdings Inc (SONN)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.12 | -8 | 1.5 | 1.54 | 1.3 | 47246 | 1.44642356 | CS |
| 4 | -0.2 | -12.6582278481 | 1.58 | 1.64 | 1.3 | 72078 | 1.50196972 | CS |
| 12 | -0.4 | -22.4719101124 | 1.78 | 2.52 | 1.3 | 176414 | 1.69073594 | CS |
| 26 | -5.58 | -80.1724137931 | 6.96 | 10 | 1.3 | 742694 | 2.56006837 | CS |
| 52 | -15.02 | -91.5853658537 | 16.4 | 18.7192 | 1.3 | 419141 | 3.58060638 | CS |
| 156 | -737.5736 | -99.8132494381 | 738.9536 | 1649.4016 | 1.3 | 1882303 | 548.3442857 | CS |
| 260 | -15324.7 | -99.9909957406 | 15326.08 | 39916.8 | 1.3 | 2237779 | 2543.4986711 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
